Drug Development

LAW AND MEDICINE 21m 13s Medicaid Use and Spending for Drugs With FDA Accelerated Approval JAMA Health Forum

CLINICAL PHARMACY AND PHARMACOLOGY 1 Credit CME Association of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer JAMA Oncology

CRITICAL CARE MEDICINE 47m 41s 1 Credit CME Coronavirus Update With Peter Piot, MD, PhD JAMA

CRITICAL CARE MEDICINE 38m 26s 1 Credit CME Coronavirus Update With Peter Piot, MD, PhD JAMA

ADDICTION MEDICINE 21m 26s Coronavirus Update With CDC Director Rochelle Walensky JAMA

ADDICTION MEDICINE 24m 59s 1 Credit CME Coronavirus Update With CDC Director Rochelle Walensky, MD JAMA

HEALTH POLICY 1 Credit CME US Food and Drug Administration Support for Oncology Drug Development During COVID-19 JAMA Oncology

CORONAVIRUS (COVID-19) 1 Credit CME Therapy for Early COVID-19: A Critical Need JAMA

CORONAVIRUS (COVID-19) 1 Credit CME The Challenges Ahead With Monoclonal Antibodies: From Authorization to Access JAMA

CORONAVIRUS (COVID-19) 1 Credit CME Study Aims to Identify Drugs That Could Be Repurposed for COVID-19 JAMA

CLINICAL PHARMACY AND PHARMACOLOGY 31m 28s 1 Credit CME Ten Things Every New Doctor Should Know About Drug Reactions JAMA

CORONAVIRUS (COVID-19) 1 Credit CME Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies JAMA Internal Medicine

CLINICAL PHARMACY AND PHARMACOLOGY 12m 50s 1 Credit CME Update on Dexamethasone for the Treatment of COVID-19 JAMA

DRUG DEVELOPMENT 1 Credit CME Missed Opportunities on Emergency Remdesivir Use JAMA

CLINICAL PHARMACY AND PHARMACOLOGY 36m 28s 1 Credit CME Remdesivir and Dexamethasone for the Treatment of COVID-19 JAMA

DRUG DEVELOPMENT 5m 46s Monoclonal Antibodies for Coronavirus JAMA

DRUG DEVELOPMENT 1 Credit CME The Equitable Distribution of COVID-19 Therapeutics and Vaccines JAMA

CORONAVIRUS (COVID-19) 1 Credit CME Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times JAMA

VACCINATION 37m 56s 1 Credit CME The NIH Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative JAMA

VACCINATION 39m 37s 1 Credit CME The NIH Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative JAMA